How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease
Search results for: rituximab
Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis
New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Why Antiphospholipid Antibody Syndrome Should Be On Your Radar
With a wide range of clinical manifestations and frequent occurrence among rheumatology patients, APS is one for rheumatologists to watch
Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life
Differences in disease manifestations, severity, and management require special consideration from rheumatologists who treat children and adolescents with systemic lupus erythematosus
Inflammatory Myopathies Difficult to Diagnose, Treat
Without a single set of diagnostic criteria for identifying polymyositis, dermatomyositis, or myositis and scant evidence-based therapeutic guidelines, these rare muscle diseases can be hard to manage
2013 ACR/ARHP Annual Meeting: Rheumatology Year in Review
Progress in treatments for pediatric rheumatic diseases, collaborative clinical trials, and personalized therapeutic approaches highlight the past year in rheumatology
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
EULAR 2013: Researchers Expand Targets for PsA, OA Therapy
Experts discuss insights in the pathogenesis of psoriatic arthritis and the role of subchondral bone in osteoarthritis
EULAR 2013: Drugs New and Old Could Treat Spondylarthropies
Nonsteroidal anti-inflammatory drugs (NSAIDs) might still have a role in treating axial spondylarthritis, but other drugs, therapies are being explored
- « Previous Page
- 1
- …
- 35
- 36
- 37
- 38
- 39
- …
- 43
- Next Page »